MedTrace Logo

SIGIL: Signal Interpretation and Analysis In Real Life Cardiac Arrhythmias

NCT05508880 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2022-08-19

No results posted yet for this study

Summary

This study essentially consists of the prospective collection of mapping data derived from patients undergoing clinically indicated 3D mapping procedures. There is no intervention. The mapping data is used to construct and/or validate new activation mapping algorithms but will not be used to direct clinical treatment of the patient.

Conditions

  • Cardiac Arrhythmia

Sponsors & Collaborators

  • Duke-NUS Graduate Medical School

    collaborator OTHER

  • National Heart Centre Singapore

    lead OTHER

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-30
Primary Completion
2023-05-30
Completion
2023-05-30

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05508880 on ClinicalTrials.gov